Policy and is co-author of the forthcoming book, Deconstructing Toxic Narratives: Data, Disparities, and a New Path Forward in the Opioid Crisis, to be published by Springer Nature.
Obes Res Clin Pract 2025;19:77-9.ArticlePubMed 99
11 John Cronin, MD, senior vice president of clinical development at Apnimed, underscores the need for diverse treatment options
Your Partners in Health While you may notice some early benefits in the first month, the most significant improvements in both blood sugar control and weight management usually develop over several months of ongoing, consistent use
We recognize that every patients journey is unique, and the effectiveness of GLP-1 medications can vary